Esbriet TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: pirfenidone
Brand name
(ARTG)
: ESBRIET pirfenidone 267 mg hard capsule bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ESBRIET is indicated for the treatment of idiopathic pulmonary fibrosis (IPF)
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- Hard gelatin capsule with a white to off white opaque body, white opaque caps with PFD 267 mg printed in brown ink
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 270 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient pirfenidone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems